DoJ Sets Its Sights On DESI Drugs: Eon Labs Settles Claims It Marketed An Ineffective Drug

Novartis subsidiary agrees to pay $3.5 million to settle claims it illegally sought government reimbursement for Nitroglycerin SR after FDA found it to be less than effective.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet